这是一篇来自已证抗体库的有关人类 ERBB4的综述,是根据28篇发表使用所有方法的文章归纳的。这综述旨在帮助来邦网的访客找到最适合ERBB4 抗体。
ERBB4 同义词: ALS19; HER4; p180erbB4

艾博抗(上海)贸易有限公司
小鼠 单克隆(HFR-1)
  • 免疫组化-石蜡切片; 人类; 1:150; 图 2
艾博抗(上海)贸易有限公司 ERBB4抗体(Abcam, ab19391)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:150 (图 2). BMC Cancer (2020) ncbi
domestic rabbit 单克隆(E200)
  • 免疫印迹; 人类; 1:1000; 图 5i
艾博抗(上海)贸易有限公司 ERBB4抗体(Abcam, E200)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 5i). Cell Mol Life Sci (2019) ncbi
domestic rabbit 单克隆(E200)
  • 流式细胞仪; 人类; 1:40; 图 5a
艾博抗(上海)贸易有限公司 ERBB4抗体(Abcam, ab32375)被用于被用于流式细胞仪在人类样本上浓度为1:40 (图 5a). Cell Death Dis (2017) ncbi
domestic rabbit 单克隆(EPR2273(2))
  • 免疫组化; 小鼠; 1:100; 图 5a
艾博抗(上海)贸易有限公司 ERBB4抗体(Abcam, ab109273)被用于被用于免疫组化在小鼠样本上浓度为1:100 (图 5a). J Clin Invest (2016) ncbi
小鼠 单克隆(HFR-1)
  • 免疫印迹; 小鼠; 图 1
艾博抗(上海)贸易有限公司 ERBB4抗体(Abcam, ab19391)被用于被用于免疫印迹在小鼠样本上 (图 1). Cell Death Dis (2015) ncbi
domestic rabbit 单克隆(EPR2273(2))
  • 免疫印迹; 小鼠; 图 1
艾博抗(上海)贸易有限公司 ERBB4抗体(Abcam, ab109273)被用于被用于免疫印迹在小鼠样本上 (图 1). Cell Death Dis (2015) ncbi
小鼠 单克隆(HFR-1)
  • 免疫组化-石蜡切片; 人类
艾博抗(上海)贸易有限公司 ERBB4抗体(Abcam, ab19391)被用于被用于免疫组化-石蜡切片在人类样本上. Cancer Prev Res (Phila) (2014) ncbi
赛默飞世尔
小鼠 单克隆(H4.77.16 (Ab77))
  • 免疫细胞化学; 小鼠; 1:300; 图 2a
赛默飞世尔 ERBB4抗体(Thermo, MA5?\12888)被用于被用于免疫细胞化学在小鼠样本上浓度为1:300 (图 2a). EMBO J (2018) ncbi
小鼠 单克隆(HFR1)
  • 免疫印迹; 小鼠; 图 3f
赛默飞世尔 ERBB4抗体(Thermo Scientific, MAI-861)被用于被用于免疫印迹在小鼠样本上 (图 3f). Sci Rep (2016) ncbi
小鼠 单克隆(H4.77.16 (Ab77))
  • 免疫组化; 小鼠; 1:300; 图 6
赛默飞世尔 ERBB4抗体(Thermo Fisher Scientific, MS-270-P0)被用于被用于免疫组化在小鼠样本上浓度为1:300 (图 6). Acta Neuropathol Commun (2016) ncbi
小鼠 单克隆(H4.72.8 (Ab72))
  • 免疫组化-冰冻切片; 小鼠; 0.003 mg/ml; 图 7
赛默飞世尔 ERBB4抗体(LabVision, mAb-77)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为0.003 mg/ml (图 7). BMC Neurosci (2013) ncbi
小鼠 单克隆(HFR1)
  • 免疫组化; 人类
赛默飞世尔 ERBB4抗体(Neomarkers, HFR1)被用于被用于免疫组化在人类样本上. Int J Cancer (2005) ncbi
安迪生物R&D
小鼠 单克隆(182818)
  • 流式细胞仪; 人类; 表 1
安迪生物R&D ERBB4抗体(R&D, MAB11311)被用于被用于流式细胞仪在人类样本上 (表 1). Int J Oncol (2016) ncbi
小鼠 单克隆(182818)
  • 流式细胞仪; 人类; 图 s2a
安迪生物R&D ERBB4抗体(R&D systems, 182818)被用于被用于流式细胞仪在人类样本上 (图 s2a). Nat Microbiol (2016) ncbi
小鼠 单克隆(182818)
  • 流式细胞仪; 人类; 表 2
安迪生物R&D ERBB4抗体(R&D Systems, MAB11311)被用于被用于流式细胞仪在人类样本上 (表 2). Int J Oncol (2016) ncbi
小鼠 单克隆(182818)
  • 流式细胞仪; 人类; 表 1
安迪生物R&D ERBB4抗体(R&D, MAB11311)被用于被用于流式细胞仪在人类样本上 (表 1). PLoS ONE (2015) ncbi
LifeSpan Biosciences
domestic rabbit 多克隆
  • 免疫组化-石蜡切片; 人类; 1:100; 图 2
  • 免疫组化; 人类
  • 免疫印迹; 人类
LifeSpan Biosciences ERBB4抗体(LifeSpan Biosciences, LS-C97506)被用于被用于免疫组化-石蜡切片在人类样本上浓度为1:100 (图 2), 被用于免疫组化在人类样本上 和 被用于免疫印迹在人类样本上. Oncogenesis (2016) ncbi
Novus Biologicals
小鼠 单克隆(H4.77.16 (Ab77))
  • 免疫组化-冰冻切片; 小鼠; 1:100; 图 4a
Novus Biologicals ERBB4抗体(Novus Biologicals, H4.77.16)被用于被用于免疫组化-冰冻切片在小鼠样本上浓度为1:100 (图 4a). Transl Psychiatry (2017) ncbi
赛信通(上海)生物试剂有限公司
domestic rabbit 单克隆(111B2)
  • 免疫印迹; 人类; 1:1000; 图 s4b
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling, 4795)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 s4b). Cancers (Basel) (2020) ncbi
domestic rabbit 单克隆(21A9)
  • 免疫印迹; 人类; 1:500; 图 5i
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling Technology, 21A9)被用于被用于免疫印迹在人类样本上浓度为1:500 (图 5i). Cell Mol Life Sci (2019) ncbi
domestic rabbit 单克隆(111B2)
  • 免疫印迹; 人类; 图 5e
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling, 4795)被用于被用于免疫印迹在人类样本上 (图 5e). Cell Res (2018) ncbi
domestic rabbit 单克隆(21A9)
  • 免疫印迹; 人类; 图 5e
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling, 4757)被用于被用于免疫印迹在人类样本上 (图 5e). Cell Res (2018) ncbi
domestic rabbit 单克隆(21A9)
  • 免疫印迹; 人类; 1:1000; 图 3e
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling, 21A9)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3e). Transl Psychiatry (2017) ncbi
domestic rabbit 单克隆(21A9)
  • 免疫印迹; 人类; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling, 4757)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3). J Cancer Res Clin Oncol (2017) ncbi
domestic rabbit 单克隆(111B2)
  • 免疫印迹; 人类; 1:1000; 图 3
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling, 4795)被用于被用于免疫印迹在人类样本上浓度为1:1000 (图 3). J Cancer Res Clin Oncol (2017) ncbi
domestic rabbit 单克隆(111B2)
  • 免疫印迹; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell signaling, 4795)被用于被用于免疫印迹在小鼠样本上 (图 1). PLoS ONE (2016) ncbi
domestic rabbit 单克隆(21A9)
  • 免疫印迹; 小鼠; 图 1
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell signaling, 4757)被用于被用于免疫印迹在小鼠样本上 (图 1). PLoS ONE (2016) ncbi
domestic rabbit 单克隆(111B2)
  • 免疫印迹; 人类; 1:850
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling, 4795)被用于被用于免疫印迹在人类样本上浓度为1:850. J Biol Chem (2015) ncbi
domestic rabbit 单克隆(111B2)
  • 免疫印迹; 人类; 1:200; 图 1
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell signaling, 4795)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 1). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(21A9)
  • 免疫印迹; 人类; 1:200; 图 1
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell signaling, 4757)被用于被用于免疫印迹在人类样本上浓度为1:200 (图 1). PLoS ONE (2015) ncbi
domestic rabbit 单克隆(21A9)
  • 免疫印迹; 人类
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling Technology, 4757)被用于被用于免疫印迹在人类样本上. Oncogene (2016) ncbi
domestic rabbit 单克隆(111B2)
  • 免疫印迹; 人类; 图 3
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling Technology, 4795)被用于被用于免疫印迹在人类样本上 (图 3). Int J Oncol (2015) ncbi
domestic rabbit 单克隆(21A9)
  • 免疫印迹; 人类; 图 5
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell signaling, 4757)被用于被用于免疫印迹在人类样本上 (图 5). J Biol Chem (2014) ncbi
domestic rabbit 单克隆(111B2)
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling, 4795)被用于被用于免疫印迹在人类样本上 (图 2). Mol Carcinog (2014) ncbi
domestic rabbit 单克隆(21A9)
  • 免疫印迹; 人类; 图 2
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling, 4757)被用于被用于免疫印迹在人类样本上 (图 2). Mol Carcinog (2014) ncbi
domestic rabbit 单克隆(111B2)
  • 免疫印迹; 小鼠; 1:1000
赛信通(上海)生物试剂有限公司 ERBB4抗体(Cell Signaling, 111B2)被用于被用于免疫印迹在小鼠样本上浓度为1:1000. Dev Biol (2013) ncbi
文章列表
  1. Padthaisong S, Thanee M, Namwat N, Phetcharaburanin J, Klanrit P, Khuntikeo N, et al. A panel of protein kinase high expression is associated with postoperative recurrence in cholangiocarcinoma. BMC Cancer. 2020;20:154 pubmed 出版商
  2. Rao L, Giannico D, Leone P, Solimando A, Maiorano E, Caporusso C, et al. HB-EGF-EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma. Cancers (Basel). 2020;12: pubmed 出版商
  3. Wintgens J, Wichert S, Popovic L, Rossner M, Wehr M. Monitoring activities of receptor tyrosine kinases using a universal adapter in genetically encoded split TEV assays. Cell Mol Life Sci. 2019;76:1185-1199 pubmed 出版商
  4. Muller T, Braud S, Jüttner R, Voigt B, Paulick K, Sheean M, et al. Neuregulin 3 promotes excitatory synapse formation on hippocampal interneurons. EMBO J. 2018;37: pubmed 出版商
  5. Xue Z, Vis D, Bruna A, Sustic T, van Wageningen S, Batra A, et al. MAP3K1 and MAP2K4 mutations are associated with sensitivity to MEK inhibitors in multiple cancer models. Cell Res. 2018;28:719-729 pubmed 出版商
  6. Kawata M, Morikawa S, Shiosaka S, Tamura H. Ablation of neuropsin-neuregulin 1 signaling imbalances ErbB4 inhibitory networks and disrupts hippocampal gamma oscillation. Transl Psychiatry. 2017;7:e1052 pubmed 出版商
  7. Schumacher M, Hedl M, Abraham C, Bernard J, Lozano P, Hsieh J, et al. ErbB4 signaling stimulates pro-inflammatory macrophage apoptosis and limits colonic inflammation. Cell Death Dis. 2017;8:e2622 pubmed 出版商
  8. Kneissl J, Hartmann A, Pfarr N, Erlmeier F, Lorber T, Keller S, et al. Influence of the HER receptor ligand system on sensitivity to cetuximab and trastuzumab in gastric cancer cell lines. J Cancer Res Clin Oncol. 2017;143:573-600 pubmed 出版商
  9. Shekhar A, Lin X, Liu F, Zhang J, Mo H, Bastarache L, et al. Transcription factor ETV1 is essential for rapid conduction in the heart. J Clin Invest. 2016;126:4444-4459 pubmed 出版商
  10. Puvanenthiran S, Essapen S, Seddon A, Modjtahedi H. Impact of the putative cancer stem cell markers and growth factor receptor expression on the sensitivity of ovarian cancer cells to treatment with various forms of small molecule tyrosine kinase inhibitors and cytotoxic drugs. Int J Oncol. 2016;49:1825-1838 pubmed 出版商
  11. Kabanova A, Marcandalli J, Zhou T, Bianchi S, Baxa U, Tsybovsky Y, et al. Platelet-derived growth factor-α receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer. Nat Microbiol. 2016;1:16082 pubmed 出版商
  12. Huh S, Baek S, Lee K, Whitcomb D, Jo J, Choi S, et al. The reemergence of long-term potentiation in aged Alzheimer's disease mouse model. Sci Rep. 2016;6:29152 pubmed 出版商
  13. Lasiene J, Komine O, Fujimori Tonou N, Powers B, Endo F, Watanabe S, et al. Neuregulin 1 confers neuroprotection in SOD1-linked amyotrophic lateral sclerosis mice via restoration of C-boutons of spinal motor neurons. Acta Neuropathol Commun. 2016;4:15 pubmed 出版商
  14. Ioannou N, Seddon A, Dalgleish A, Mackintosh D, Solca F, Modjtahedi H. Acquired resistance of pancreatic cancer cells to treatment with gemcitabine and HER-inhibitors is accompanied by increased sensitivity to STAT3 inhibition. Int J Oncol. 2016;48:908-18 pubmed 出版商
  15. Roßner F, Gieseler C, Morkel M, Royer H, Rivera M, Bläker H, et al. Uncoupling of EGFR-RAS signaling and nuclear localization of YBX1 in colorectal cancer. Oncogenesis. 2016;5:e187 pubmed 出版商
  16. Wandinger S, Lahortiga I, Jacobs K, Klammer M, Jordan N, Elschenbroich S, et al. Quantitative Phosphoproteomics Analysis of ERBB3/ERBB4 Signaling. PLoS ONE. 2016;11:e0146100 pubmed 出版商
  17. Zomerman W, Plasschaert S, Diks S, Lourens H, Meeuwsen de Boer T, Hoving E, et al. Exogenous HGF Bypasses the Effects of ErbB Inhibition on Tumor Cell Viability in Medulloblastoma Cell Lines. PLoS ONE. 2015;10:e0141381 pubmed 出版商
  18. Higa Nakamine S, Maeda N, Toku S, Yamamoto H. Involvement of Protein Kinase D1 in Signal Transduction from the Protein Kinase C Pathway to the Tyrosine Kinase Pathway in Response to Gonadotropin-releasing Hormone. J Biol Chem. 2015;290:25974-85 pubmed 出版商
  19. Blancafort A, Giró Perafita A, Oliveras G, Palomeras S, Turrado C, Campuzano Ã, et al. Dual fatty acid synthase and HER2 signaling blockade shows marked antitumor activity against breast cancer models resistant to anti-HER2 drugs. PLoS ONE. 2015;10:e0131241 pubmed 出版商
  20. Kurppa K, Denessiouk K, Johnson M, Elenius K. Activating ERBB4 mutations in non-small cell lung cancer. Oncogene. 2016;35:1283-91 pubmed 出版商
  21. Liang X, Ding Y, Zhang Y, Chai Y, He J, Chiu S, et al. Activation of NRG1-ERBB4 signaling potentiates mesenchymal stem cell-mediated myocardial repairs following myocardial infarction. Cell Death Dis. 2015;6:e1765 pubmed 出版商
  22. Hole S, Pedersen A, Hansen S, Lundqvist J, Yde C, Lykkesfeldt A. New cell culture model for aromatase inhibitor-resistant breast cancer shows sensitivity to fulvestrant treatment and cross-resistance between letrozole and exemestane. Int J Oncol. 2015;46:1481-90 pubmed 出版商
  23. Paatero I, Seagroves T, Vaparanta K, Han W, Jones F, Johnson R, et al. Hypoxia-inducible factor-1? induces ErbB4 signaling in the differentiating mammary gland. J Biol Chem. 2014;289:22459-69 pubmed 出版商
  24. Gruessner C, Gruessner A, Glaser K, Abushahin N, Zhou Y, Laughren C, et al. Flutamide and biomarkers in women at high risk for ovarian cancer: preclinical and clinical evidence. Cancer Prev Res (Phila). 2014;7:896-905 pubmed 出版商
  25. Brouxhon S, Kyrkanides S, Teng X, O Banion M, Clarke R, Byers S, et al. Soluble-E-cadherin activates HER and IAP family members in HER2+ and TNBC human breast cancers. Mol Carcinog. 2014;53:893-906 pubmed 出版商
  26. Amschl D, Neddens J, Havas D, Flunkert S, Rabl R, Römer H, et al. Time course and progression of wild type ?-synuclein accumulation in a transgenic mouse model. BMC Neurosci. 2013;14:6 pubmed 出版商
  27. Harmelink C, Peng Y, Debenedittis P, Chen H, Shou W, Jiao K. Myocardial Mycn is essential for mouse ventricular wall morphogenesis. Dev Biol. 2013;373:53-63 pubmed 出版商
  28. Abd El Rehim D, Ball G, Pinder S, Rakha E, Paish C, Robertson J, et al. High-throughput protein expression analysis using tissue microarray technology of a large well-characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer. 2005;116:340-50 pubmed